Excretion study of the β2-agonist reproterol in human urine

C.G Georgakopoulos1, C Tsitsimpikou1, M.-H.E Spyridaki1
1Doping Control Laboratory of Athens, Olympic Athletic Center of Athens, Kifissias 37, 15123 Maroussi, Greece

Tài liệu tham khảo

Polettini, 1996, J. Chromatogr. B, 687, 27, 10.1016/S0378-4347(96)00015-1 Georgakopoulos, 1999, Trends Anal. Chem., 18, 1, 10.1016/S0165-9936(98)00101-0 International Olympic Committee Medical Code and Explanatory Document, <www.olympic.org>. van Rhijn, 1995, J. Chromatogr. B, 665, 395, 10.1016/0378-4347(94)00546-H Doerge, 1995, J. Mass Spectrom., 30, 911, 10.1002/jms.1190300617 Boyd, 1996, Analyst, 212, 1R, 10.1039/AN996210001R Hogendoorn, 1998, Anal. Chem., 70, 1362, 10.1021/ac971030w Verini, 1985, J. Int. Med. Res., 13, 19, 10.1177/030006058501300103 Palma-Carlos, 1986, Allerg. Immunol., 18, 31 Niebch, 1978, Arzneim. Forsch., 28, 765 Niebch, 1977, Arzneim. Forsch., 27, 37 Hageman, 1988, Biopharm. Drug Dispos., 9, 301, 10.1002/bod.2510090308 Hageman, 1983, J. Chromatogr., 274, 239, 10.1016/S0378-4347(00)84427-8 Knebel, 1997, J. Chromatogr. B, 702, 119, 10.1016/S0378-4347(97)00381-2 Donike, 1987, 53